BIOTRICITY INC. Receives Nasdaq Delisting Notice for Bid Price Non-Compliance

TL;DR

**BIOTRICITY got a Nasdaq delisting notice for low stock price, big trouble for investors.**

AI Summary

BIOTRICITY INC. (BTCY) announced on January 30, 2024, that it received a delisting notice from the Nasdaq Capital Market because its common stock failed to maintain the minimum bid price of $1.00 per share. This is a critical development for investors because if the company cannot regain compliance, its shares could be delisted, potentially moving to an over-the-counter market, which often leads to decreased liquidity and investor interest.

Why It Matters

This notice signals significant financial instability for BIOTRICITY INC., potentially leading to its stock being delisted from Nasdaq, which could severely impact its stock's liquidity and investor confidence.

Risk Assessment

Risk Level: high — The risk is high because delisting from a major exchange like Nasdaq can significantly reduce a stock's visibility, liquidity, and investor appeal.

Analyst Insight

A smart investor would closely monitor BIOTRICITY INC.'s efforts to regain Nasdaq compliance and consider the potential for delisting, which could lead to reduced liquidity and further price depreciation. This filing suggests a need for caution or re-evaluation of holding BTCY shares.

Key Numbers

• $0.001 — Par Value of Common Stock (The stated par value of BIOTRICITY INC.'s common stock.)
• $1.00 — Minimum Bid Price (The Nasdaq Capital Market's minimum bid price requirement that BIOTRICITY INC. failed to satisfy.)

Key Players & Entities

• BIOTRICITY INC. (company) — the registrant receiving the delisting notice
• Nasdaq Capital Market (company) — the exchange from which BIOTRICITY INC. faces delisting
• $1.00 (dollar_amount) — the minimum bid price requirement
• January 30, 2024 (date) — date of the earliest event reported regarding the delisting notice
• BTCY (company) — BIOTRICITY INC.'s trading symbol

Forward-Looking Statements

• BIOTRICITY INC. will struggle to regain Nasdaq compliance within the typical grace period. (BIOTRICITY INC.) — medium confidence, target: 2024-07-30
• The stock price of BTCY will experience increased volatility. (BTCY) — high confidence, target: 2024-04-30

FAQ

Key Financial Figures

• $0.001 B — ch registered Common Stock, Par Value $0.001 BTCY Nasdaq Capital Market Indicate
• $35 million — isted Securities ("MVLS") was below the $35 million minimum requirement for continued inclu
• $35 million — ompany's MVLS did not close at or above $35 million for a minimum of 10 consecutive busines

Filing Documents

• form8-k.htm (8-K) — 36KB
• 0001493152-24-004806.txt ( ) — 205KB
• btcy-20240130.xsd (EX-101.SCH) — 3KB
• btcy-20240130_lab.xml (EX-101.LAB) — 33KB
• btcy-20240130_pre.xml (EX-101.PRE) — 22KB
• form8-k_htm.xml (XML) — 4KB

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Date: February 2, 2024 BIOTRICITY INC. By: /s/ Waqaas Al-Siddiq Waqaas Al-Siddiq Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR